Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Activating TLR3 may help produce retinoic acid, important for tissue regeneration.

CRF can cause hair loss, but blocking its receptors might prevent this.

Mitochondrial activity varies in cells before they stop growing, affecting their growth potential.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Regulatory T cells enhance bone formation by influencing cell mechanics.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

A new laser technique can precisely remove specific cell types in living animals without harming nearby cells.

Adipose-derived stem cell-conditioned medium can reduce melanoma cell growth and spread.

Controlling transposable elements is crucial for successful tissue regeneration.

Melatonin affects skin cell growth differently based on how much and how long it's used.

Protein kinase C epsilon may increase skin cancer risk by affecting nearby cells.

Skin stem cells help create protective immune cells during wound healing.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Terbinafine effectively treated kerion celsi despite disrupted immune responses.

MC-1R is present in skin cells and may help reduce inflammation.

Melatonin affects cell growth differently based on its concentration.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Blocking IL-12 can help treat alopecia areata by preventing hair follicle immune issues.

A specific group of early-stage melanocytes is reduced in vitiligo-affected skin, which may explain treatment resistance.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.